SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001437749-24-018624
Filing Date
2024-05-29
Accepted
2024-05-29 17:58:18
Documents
1
Period of Report
2024-05-24

Document Format Files

Seq Description Document Type Size
1 OPTION GRANT rdgdoc.html 4  
1 OPTION GRANT rdgdoc.xml 4 6195
  Complete submission text file 0001437749-24-018624.txt   7745
Mailing Address 10578 SCIENCE CENTER DRIVE, SUITE 200 SAN DIEGO CA 92121
Business Address 10578 SCIENCE CENTER DRIVE, SUITE 200 SAN DIEGO CA 92121 (858) 333-5280
Contineum Therapeutics, Inc. (Issuer) CIK: 0001855175 (see all company filings)

IRS No.: 271467257 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 10578 SCIENCE CENTER DRIVE, SUITE 200 SAN DIEGO CA 92121
Business Address
Lorrain Daniel S. (Reporting) CIK: 0001861550 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-42001 | Film No.: 241000011